Roche Holding AG (SWX:RO)
265.40
-1.80 (-0.67%)
Sep 26, 2025, 5:31 PM CET
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
614.90K CHF
Profits / Employee
91.32K CHF
Market Cap
217.47B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 103,249 | -356 | -0.34% |
Dec 31, 2023 | 103,605 | -8 | -0.01% |
Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
Dec 31, 2021 | 100,920 | -545 | -0.54% |
Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Roche Holding AG | 103,249 |
Novartis AG | 75,883 |
Lonza Group AG | 18,944 |
Galderma Group AG | 6,545 |
Alcon | 25,599 |
Sandoz Group AG | 22,049 |
Straumann Holding AG | 11,815 |
Sonova Holding AG | 18,366 |
Roche Holding AG News
- 2 days ago - Roche points to U.S. plans after Trump pharma tariff announcement - Reuters
- 3 days ago - Kodiak gains as Barclays upgrades on Roche data for eye disease drug - Seeking Alpha
- 3 days ago - Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial - CNBC
- 4 days ago - Roche presents new data for OCREVUS and fenebrutinib across broad patient populations at ECTRIMS 2025 - GlobeNewsWire
- 4 days ago - Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025 - Business Wire
- 5 days ago - Roche's Giredestrant: A Ray Of Hope On A Cloudy Horizon? - Seeking Alpha
- 5 days ago - Roche Holding AG - Special Call - Seeking Alpha
- 6 days ago - Roche Targets Top Spot In Weight Loss Drug Market - Benzinga